Skip to main content
Log in

Cilazapril decomposition kinetics and mechanism in the solid state versus stability of the other ester pro-drug angiotensin converting enzyme inhibitors

  • Published:
Reaction Kinetics, Mechanisms and Catalysis Aims and scope Submit manuscript

Abstract

The presented study aimed at the evaluation of the chemical stability properties of cilazapril during isothermal kinetic tests, subsequent identification of the degradation product and proposition of a probable mechanism of cilazapril degradation. Identification analyses gave undeniable evidence that cilazapril degrades in course of deesterification reaction forming cilazaprilat. This transformation has negative implications, since cilazaprilat, although biologically active, is not capable of being absorbed from gastrointestinal tract. Thermal analyses pointed out that the kinetic model of cilazapril degradation in solid state depends on the presence of moisture in the surrounding environment. Under the conditions of increased relative humidity levels, changes in cilazapril concentration during the degradation process can be expressed by the Prout–Tompkins relationship. The decomposition process occurs more rapidly, while increasing both the relative humidity (lnk = (0.036 ± 0.006) RH - (13.53 ± 0.23)) and the temperature (lnk = (−20025.3 ± 2500.3) 1/T + (44.21 ± 7.19)). On the other hand, the lack of moisture in air generates a change in the kinetic model of reaction. In the absence of humidity, a different reaction model is suggested with two reaction stages. Here the increase of temperature also affects both stages of the reaction in linear semi-logarithmic way (lnk 1 = (−10394.4 ± 1976.8) 1/T + (15.15 ± 5.18) and lnk 2 = (−13255.9 ± 2679.2) 1/T + (20.82 ± 7.02)). The obtained results enabled a comparison with other angiotensin enzyme inhibitors similar in structure, which showed that cilazapril in the solid state is characterized by the best chemical stability (E a  = 166.50 ± 20.79 kJ mol−1).

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8
Fig. 9
Fig. 10

Similar content being viewed by others

References

  1. Council of Europe (2010) European directorate for the quality of medicines and healthcare. European Pharmacopoeia, Strasbourg

    Google Scholar 

  2. Opie LH (1999) Angiotensin-converting enzyme inhibitors. The advance continues. Authors’ Publishing House, New York

    Google Scholar 

  3. Attwood MR (1989) Br J Clin Pharmacol 27(Suppl 2):133S–137S

    Article  CAS  Google Scholar 

  4. Waterfall JF (1989) Br J Clin Pharmacol 27(Suppl 2):139S–150S

    Article  CAS  Google Scholar 

  5. Szucs T, Schneeweiss A (1992) Cardiology 80:34–41

    Article  CAS  Google Scholar 

  6. Byrn SR, Xu W, Newman AW (2001) Adv Drug Deliv Rev 48:115–136

    Article  CAS  Google Scholar 

  7. Yoshioka S, Stella VJ (2002) Stability of drugs and dosage forms. Kulwer Academic Publishers, New York

    Google Scholar 

  8. Stanisz B (2003) J Pharm Biomed Anal 31:375–380

    Article  CAS  Google Scholar 

  9. Stanisz B (2003) Acta Pol Pharm 60:443–450

    CAS  Google Scholar 

  10. Stanisz B (2004) J Liq Chromatogr Relat Tech 27:3103–3119

    CAS  Google Scholar 

  11. Stanisz B (2004) Acta Pol Pharm 61:91–97

    CAS  Google Scholar 

  12. Paszun SK, Stanisz BJ, Pawłowski W (2012) Acta Pol Pharm 70:193–201

    Google Scholar 

  13. Brown ME (1997) Thermochim Acta 30:93–106

    Article  Google Scholar 

  14. Pawełczyk E, Hermann T (1982) Podstawy trwałości leków (Principles of drug stability). PZWL, Warsaw

    Google Scholar 

Download references

Acknowledgments

The research was funded by the Polish National Science Centre (Grant No. NN405 050440).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Sylwia Katarzyna Paszun.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Paszun, S.K., Stanisz, B.J. Cilazapril decomposition kinetics and mechanism in the solid state versus stability of the other ester pro-drug angiotensin converting enzyme inhibitors. Reac Kinet Mech Cat 109, 285–300 (2013). https://doi.org/10.1007/s11144-013-0558-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11144-013-0558-1

Keywords

Navigation